351 related articles for article (PubMed ID: 8710935)
41. Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: studies with chimeric receptors.
Ellis J; Seidenberg M
Mol Pharmacol; 2000 Dec; 58(6):1451-60. PubMed ID: 11093785
[TBL] [Abstract][Full Text] [Related]
42. Histamine H1 receptor down-regulation mediated by M3 muscarinic acetylcholine receptor subtype.
Miyoshi K; Kawakami N; Wakayama Y; Izumi N; Horio S; Fukui H
J Pharmacol Sci; 2004 Aug; 95(4):426-34. PubMed ID: 15286428
[TBL] [Abstract][Full Text] [Related]
43. Stimulation of cyclic AMP production by the Caenorhabditis elegans muscarinic acetylcholine receptor GAR-3 in Chinese hamster ovary cells.
Park YS; Cho TJ; Cho NJ
Arch Biochem Biophys; 2006 Jun; 450(2):203-7. PubMed ID: 16631594
[TBL] [Abstract][Full Text] [Related]
44. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
Lazareno S; Birdsall NJ
Mol Pharmacol; 1995 Aug; 48(2):362-78. PubMed ID: 7651370
[TBL] [Abstract][Full Text] [Related]
45. Human muscarinic receptors expressed in A9L and CHO cells: activation by full and partial agonists.
Richards MH; van Giersbergen PL
Br J Pharmacol; 1995 Mar; 114(6):1241-9. PubMed ID: 7620715
[TBL] [Abstract][Full Text] [Related]
46. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.
Birdsall NJ; Farries T; Gharagozloo P; Kobayashi S; Lazareno S; Sugimoto M
Mol Pharmacol; 1999 Apr; 55(4):778-86. PubMed ID: 10101037
[TBL] [Abstract][Full Text] [Related]
47. Independent induction of morphological transformation of CHO cells by receptor-activated cyclic AMP synthesis or by receptor-operated calcium influx.
Singer-Lahat D; Ma AL; Felder CC
Biochem Pharmacol; 1996 Feb; 51(4):495-502. PubMed ID: 8619896
[TBL] [Abstract][Full Text] [Related]
48. Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.
Gharagozloo P; Lazareno S; Popham A; Birdsall NJ
J Med Chem; 1999 Feb; 42(3):438-45. PubMed ID: 9986715
[TBL] [Abstract][Full Text] [Related]
49. Cardioselective derivatives of 2,2-diphenyl-2-ethylthioacetate do not discriminate between m2 and m3 muscarinic receptors expressed in CHO cells.
Hu J; Wang SZ; Scapecchi S; Gualtieri F; el-Fakahany EE
Pharmacology; 1995 May; 50(5):273-85. PubMed ID: 7667389
[TBL] [Abstract][Full Text] [Related]
50. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry.
Wood MD; Murkitt KL; Ho M; Watson JM; Brown F; Hunter AJ; Middlemiss DN
Br J Pharmacol; 1999 Apr; 126(7):1620-4. PubMed ID: 10323594
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the pharmacological antagonism of M2 and M3 muscarinic receptors expressed in isolation and in combination.
Griffin MT; Hsu JC; Shehnaz D; Ehlert FJ
Biochem Pharmacol; 2003 Apr; 65(8):1227-41. PubMed ID: 12694864
[TBL] [Abstract][Full Text] [Related]
52. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor.
Ehlert FJ; Griffin MT; Glidden PF
J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358
[TBL] [Abstract][Full Text] [Related]
53. Differential effects of the M1-M5 muscarinic acetylcholine receptor subtypes on intracellular calcium and on the incorporation of choline into membrane lipids in genetically modified Chinese hamster ovary cell lines.
Dolezal V; Lisá V; Tucek S
Brain Res Bull; 1997; 42(1):71-8. PubMed ID: 8978936
[TBL] [Abstract][Full Text] [Related]
54. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
[TBL] [Abstract][Full Text] [Related]
55. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
[TBL] [Abstract][Full Text] [Related]
56. Allosteric regulation of the binding of [3H]acetylcholine to m2 muscarinic receptors.
Gnagey A; Ellis J
Biochem Pharmacol; 1996 Dec; 52(11):1767-75. PubMed ID: 8986140
[TBL] [Abstract][Full Text] [Related]
57. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
58. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1993 Jul; 266(1):237-43. PubMed ID: 7687290
[TBL] [Abstract][Full Text] [Related]
59. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
60. Determination of [35S]guanosine-5'-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay.
DeLapp NW; McKinzie JH; Sawyer BD; Vandergriff A; Falcone J; McClure D; Felder CC
J Pharmacol Exp Ther; 1999 May; 289(2):946-55. PubMed ID: 10215674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
